Publication:
Glutamate and Brain Glutaminases in Drug Addiction.

dc.contributor.authorMarquez, Javier
dc.contributor.authorCampos-Sandoval, Jose A
dc.contributor.authorPeñalver, Ana
dc.contributor.authorMates, Jose M
dc.contributor.authorSegura, Juan A
dc.contributor.authorBlanco, Eduardo
dc.contributor.authorAlonso, Francisco J
dc.contributor.authorRodriguez-de-Fonseca, Fernando
dc.date.accessioned2023-01-25T09:42:45Z
dc.date.available2023-01-25T09:42:45Z
dc.date.issued2016-12-23
dc.description.abstractGlutamate is the principal excitatory neurotransmitter in the central nervous system and its actions are related to the behavioral effects of psychostimulant drugs. In the last two decades, basic neuroscience research and preclinical studies with animal models are suggesting a critical role for glutamate transmission in drug reward, reinforcement, and relapse. Although most of the interest has been centered in post-synaptic glutamate receptors, the presynaptic synthesis of glutamate through brain glutaminases may also contribute to imbalances in glutamate homeostasis, a key feature of the glutamatergic hypothesis of addiction. Glutaminases are the main glutamate-producing enzymes in brain and dysregulation of their function have been associated with neurodegenerative diseases and neurological disorders; however, the possible implication of these enzymes in drug addiction remains largely unknown. This mini-review focuses on brain glutaminase isozymes and their alterations by in vivo exposure to drugs of abuse, which are discussed in the context of the glutamate homeostasis theory of addiction. Recent findings from mouse models have shown that drugs induce changes in the expression profiles of key glutamatergic transmission genes, although the molecular mechanisms that regulate drug-induced neuronal sensitization and behavioral plasticity are not clear.
dc.description.versionSi
dc.identifier.citationMárquez J, Campos-Sandoval JA, Peñalver A, Matés JM, Segura JA, Blanco E, et al. Glutamate and Brain Glutaminases in Drug Addiction. Neurochem Res. 2017 Mar;42(3):846-857
dc.identifier.doi10.1007/s11064-016-2137-0
dc.identifier.essn1573-6903
dc.identifier.pmid28012058
dc.identifier.unpaywallURLhttps://repositori.udl.cat/bitstream/10459.1/63098/3/026089.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10711
dc.issue.number3
dc.journal.titleNeurochemical research
dc.journal.titleabbreviationNeurochem Res
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Regional de Málaga
dc.page.number846-857
dc.provenanceRealizada la curación de contenido 17/02/2025
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsCC0 1.0 Universal
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/
dc.subjectCocaine
dc.subjectDrugs of abuse
dc.subjectGlutamate
dc.subjectGlutamatergic neuroadaptations
dc.subjectGlutaminase
dc.subjectSynaptic plasticity
dc.subject.decsDrogas ilícitas
dc.subject.decsEncéfalo
dc.subject.decsEndocannabinoides
dc.subject.decsGlutaminasa
dc.subject.decsHomeostasis
dc.subject.decsIsoenzimas
dc.subject.decsMetabolismo de los lípidos
dc.subject.decsTrastornos relacionados con sustancias
dc.subject.decsÁcido glutámico
dc.subject.meshAnimals
dc.subject.meshBrain
dc.subject.meshEndocannabinoids
dc.subject.meshGlutamic Acid
dc.subject.meshGlutaminase
dc.subject.meshHomeostasis
dc.subject.meshHumans
dc.subject.meshIllicit Drugs
dc.subject.meshIsoenzymes
dc.subject.meshLipid Metabolism
dc.subject.meshSubstance-Related Disorders
dc.titleGlutamate and Brain Glutaminases in Drug Addiction.
dc.typeresearch article
dc.type.hasVersionAM
dc.volume.number42
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format